These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 7947026)
1. The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients. Crocker JF; Renton KW; LeVatte TL; McLellan DH Pediatr Nephrol; 1994 Aug; 8(4):408-11. PubMed ID: 7947026 [TBL] [Abstract][Full Text] [Related]
2. Nifedipine, verapamil and cyclosporin A pharmacokinetics in children. Ogborn MR; Crocker JF; Grimm PC Pediatr Nephrol; 1989 Jul; 3(3):314-6. PubMed ID: 2702114 [TBL] [Abstract][Full Text] [Related]
3. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients. Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332 [TBL] [Abstract][Full Text] [Related]
4. The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients. Howard RL; Shapiro JI; Babcock S; Chan L Ren Fail; 1990; 12(2):89-92. PubMed ID: 2236731 [TBL] [Abstract][Full Text] [Related]
5. Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. Harper SJ; Moorhouse J; Veitch PS; Horsburgh T; Walls J; Bell PR; Donnelly PK; Feehally J Transpl Int; 1992; 5 Suppl 1():S69-72. PubMed ID: 14621737 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity. Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558 [TBL] [Abstract][Full Text] [Related]